Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 10:57 PM
Study NCT ID:
NCT00150267
Status:
COMPLETED
Last Update Posted:
2008-11-05
First Post:
2005-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D005902', 'term': 'Glaucoma, Open-Angle'}, {'id': 'D009798', 'term': 'Ocular Hypertension'}], 'ancestors': [{'id': 'D005901', 'term': 'Glaucoma'}, {'id': 'D005128', 'term': 'Eye Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C571753', 'term': 'Xalacom'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 976}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2002-02'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2008-11', 'lastUpdateSubmitDate': '2008-11-04', 'studyFirstSubmitDate': '2005-09-06', 'studyFirstSubmitQcDate': '2005-09-06', 'lastUpdatePostDateStruct': {'date': '2008-11-05', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2005-09-08', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Incidence of increase of iris pigmentation'}, {'measure': 'incidence of development in darkening/lengthening/thickening of eyelashes and/or pigmentation of periorbital skin'}, {'measure': 'occurrence of ocular/periorbital adverse events'}, {'measure': 'occurrence of serious adverse events.'}]}, 'conditionsModule': {'conditions': ['Glaucoma, Open-Angle', 'Ocular Hypertension']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=912-OPT-0076-019&StudyName=A%205-Year%20Postmarketing%20Safety%20Study%20Of%20Xalcom%20In%20Patients%20With%20Open%20Angle%20Glaucoma%20Or%20Ocular%20Hypertension', 'label': 'To obtain contact information for a study center near you, click here.'}]}, 'descriptionModule': {'briefSummary': 'To estimate the frequency of patients with ocular/periorbital adverse events. To identify any possible long-term adverse consequences of increased iris pigmentation and to follow serious adverse events throughout the study period.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients with open angle glaucoma and/or ocular hypertension requiring a reduction of IOP who were insufficiently responsive to topical betablockers\n\nExclusion Criteria:\n\n* Previous and current treatment with any topical ophthalmic drug containing prostaglandins; any condition in which treatment with the betablocking agent, timolol, was contraindicated.'}, 'identificationModule': {'nctId': 'NCT00150267', 'briefTitle': 'A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension', 'organization': {'class': 'INDUSTRY', 'fullName': 'Pfizer'}, 'officialTitle': 'A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension', 'orgStudyIdInfo': {'id': '912-OPT-0076-019'}}, 'armsInterventionsModule': {'interventions': [{'name': 'Xalacom', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'zip': '2000', 'city': 'Sydney', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'zip': '2067', 'city': 'Sydney', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'zip': '2020', 'city': 'Antwerp', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.22047, 'lon': 4.40026}}, {'zip': '1090', 'city': 'Brussels', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'zip': '2650', 'city': 'Edegem', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.15662, 'lon': 4.44504}}, {'zip': '9000', 'city': 'Ghent', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'zip': '3000', 'city': 'Leuven', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': 'B-4000', 'city': 'Liège', 'country': 'Belgium', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.63373, 'lon': 5.56749}}, {'zip': '2100', 'city': 'København Ø', 'country': 'Denmark', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.70968, 'lon': 12.56862}}, {'zip': '5000', 'city': 'Odense C', 'country': 'Denmark', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.40841, 'lon': 10.39538}}, {'zip': '40800', 'city': 'Aire Sur Adour', 'country': 'France', 'facility': 'Pfizer Investigational Site'}, {'zip': '11000', 'city': 'Carcassonne', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.21649, 'lon': 2.34863}}, {'zip': '21000', 'city': 'Dijon', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.31344, 'lon': 5.01391}}, {'zip': '46100', 'city': 'Figeac', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.60894, 'lon': 2.03155}}, {'zip': '67500', 'city': 'Haguenau', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.81557, 'lon': 7.79051}}, {'zip': '06110', 'city': 'Le Cannet', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.57662, 'lon': 7.01912}}, {'zip': '59120', 'city': 'Loos', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.60982, 'lon': 3.01874}}, {'zip': '13012', 'city': 'Marseille', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'zip': '75011', 'city': 'Paris', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '78000', 'city': 'Versailles', 'country': 'France', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.80359, 'lon': 2.13424}}, {'zip': '91052', 'city': 'Erlangen', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.59099, 'lon': 11.00783}}, {'zip': '85354', 'city': 'Freising', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.40351, 'lon': 11.74876}}, {'zip': '97447', 'city': 'Gerolzhofen', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.90025, 'lon': 10.34832}}, {'zip': '96114', 'city': 'Hirschaid', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.81789, 'lon': 10.98918}}, {'zip': '63768', 'city': 'Hösbach', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.00646, 'lon': 9.20765}}, {'zip': '55116', 'city': 'Mainz', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'zip': '55124', 'city': 'Mainz', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'zip': '97070', 'city': 'Würzburg', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'zip': '184 54', 'city': 'Piraeus', 'state': 'Nikea-Piraeus', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 37.94203, 'lon': 23.64619}}, {'zip': '10 672', 'city': 'Athens', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Kavala', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.93959, 'lon': 24.40687}}, {'city': 'Pátrai', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.2462, 'lon': 21.73508}}, {'city': 'Thessaloniki', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'city': 'Ennis', 'state': 'Co. Clare', 'country': 'Ireland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.84361, 'lon': -8.98639}}, {'city': 'Galway', 'country': 'Ireland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.27245, 'lon': -9.05095}}, {'zip': '23100', 'city': 'Siena', 'state': 'Siena', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.31822, 'lon': 11.33064}}, {'zip': '40138', 'city': 'Bologna', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.49381, 'lon': 11.33875}}, {'zip': '50139', 'city': 'Florence', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.77925, 'lon': 11.24626}}, {'zip': '20142', 'city': 'Milan', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'zip': '35100', 'city': 'Padua', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.40797, 'lon': 11.88586}}, {'zip': '06122', 'city': 'Perugia', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.1122, 'lon': 12.38878}}, {'zip': '56127', 'city': 'Pisa', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.70853, 'lon': 10.4036}}, {'city': 'Torino', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.88856, 'lon': 11.99138}}, {'zip': '1815 JD', 'city': 'Alkmaar', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.63167, 'lon': 4.74861}}, {'zip': '2805 AH', 'city': 'Gouda', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.01667, 'lon': 4.70833}}, {'zip': '2289 CA', 'city': 'Rijswijk', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.03634, 'lon': 4.32501}}, {'zip': '04009', 'city': 'Almería', 'state': 'Almeria', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 36.83814, 'lon': -2.45974}}, {'zip': '07500', 'city': 'Palma de Mallorca', 'state': 'Balearic Islands', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.56939, 'lon': 2.65024}}, {'zip': '08916', 'city': 'Badalona', 'state': 'Barcelona', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.45004, 'lon': 2.24741}}, {'zip': '08025', 'city': 'Barcelona', 'state': 'Barcelona', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08221', 'city': 'Terrassa', 'state': 'Barcelona', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.56667, 'lon': 2.01667}}, {'zip': '27004', 'city': 'Lugo', 'state': 'Lugo', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.00992, 'lon': -7.55602}}, {'zip': '28905', 'city': 'Getafe', 'state': 'Madrid', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.30571, 'lon': -3.73295}}, {'zip': '28034', 'city': 'Madrid', 'state': 'Madrid', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '29009', 'city': 'Málaga', 'state': 'Malaga', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 36.72016, 'lon': -4.42034}}, {'zip': '46014', 'city': 'Valencia', 'state': 'Valencia', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'zip': '47005', 'city': 'Valladolid', 'state': 'Valladolid', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.65541, 'lon': -4.72353}}, {'zip': '48903', 'city': 'Bilbao', 'state': 'Vizcaya', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.26271, 'lon': -2.92528}}, {'zip': '50009', 'city': 'Zaragoza', 'state': 'Zaragoza', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.65606, 'lon': -0.87734}}, {'city': 'Motala', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 58.53706, 'lon': 15.03649}}, {'zip': '701 85', 'city': 'Örebro', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.27412, 'lon': 15.2066}}, {'city': 'Stockholm', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.32938, 'lon': 18.06871}}, {'zip': '751 85', 'city': 'Uppsala', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.85882, 'lon': 17.63889}}, {'zip': '721 89', 'city': 'Västerås', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.61617, 'lon': 16.55276}}, {'zip': 'BS1 2LX', 'city': 'Bristol', 'state': 'Gloucestershire', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.45523, 'lon': -2.59665}}, {'zip': 'GL53 7AN', 'city': 'Cheltenham', 'state': 'Gloucestershire', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.90006, 'lon': -2.07972}}, {'city': 'Bolton', 'state': 'Lancs', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.58333, 'lon': -2.43333}}, {'zip': 'UB8 3NN', 'city': 'Uxbridge', 'state': 'Middlesex', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.5489, 'lon': -0.48211}}, {'zip': 'NR4 7UZ', 'city': 'Norwich', 'state': 'Norfolk', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.62783, 'lon': 1.29834}}, {'zip': 'RH1 5RH', 'city': 'Redhill', 'state': 'Surrey', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.24048, 'lon': -0.17044}}, {'zip': 'B9 5SS', 'city': 'Birmingham', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.48142, 'lon': -1.89983}}, {'zip': 'G4 0SF', 'city': 'Glasgow', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.86515, 'lon': -4.25763}}, {'zip': 'LA1 4RP', 'city': 'Lancaster', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.04649, 'lon': -2.79988}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}], 'overallOfficials': [{'name': 'Pfizer CT.gov Call Center', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Pfizer'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Pfizer', 'class': 'INDUSTRY'}, 'responsibleParty': {'oldNameTitle': 'Director, Clinical Trial Disclosure', 'oldOrganization': 'Pfizer, Inc.'}}}}